Thalassemia is a rare inherited blood disorder requiring lifelong blood transfusions and other medical interventions. 

Hematopoietic Stem Cell Transplantation (HSCT) or Bone Marrow Transplantation (BMT) is the only curative option for Thalassemia Major.

Thalassemia Bal Sewa Yojana (TBSY), a CSR project by GoI, funded by Coal India Ltd., supports the curative treatment of Thalassemia.

The scheme, initiated in 2017, is now extended until 2026.

TBSY provides financial assistance up to Rs. 10 lakh per case for eligible underprivileged patients.

The National Health Mission, Odisha, has recently urged medical institutions to raise awareness and publicize the scheme.

Eligible thalassemia patients with matched donors can apply through the State NHM, 11 empanelled hospitals, or the Thalasemic India Society.

A list of 11 empanelled hospitals that meet the eligibility criteria is under the Orrisa scheme.